Monashee Investment Management LLC Axogen, Inc. Transaction History

Monashee Investment Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 12, 2019	SELL	$17.09 - $38.25 $338,604 - $757,847	-19,813 Closed	0 $0
Q2 2018 Aug 10, 2018	BUY	$36.15 - $52.5 $716,239 - $1.04 Million	19,813 New	19,813 $996,000
Q1 2018 May 10, 2018	SELL	$24.4 - $40.25 $2.89 Million - $4.76 Million	-118,339 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$18.5 - $28.6 $2.19 Million - $3.38 Million	118,339	118,339 $3.35 Million

162

36.6M

230K

400

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $697M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

Get notified when there are updates to the investment portfolio of Monashee Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Monashee Investment Management LLC with notifications on news.